You are here

  • Home
  • Archive
  • Volume 95, Issue 10
  • Modelling the prevalence of age-related macular degeneration (2010–2020) in the UK: expected impact of anti-vascular endothelial growth factor (VEGF) therapy

Citation Tools

Article menu
Download PDFPDF
Clinical science
Original article
Modelling the prevalence of age-related macular degeneration (2010–2020) in the UK: expected impact of anti-vascular endothelial growth factor (VEGF) therapy

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Minassian DC, Reidy A, Lightstone A, et al
Modelling the prevalence of age-related macular degeneration (2010–2020) in the UK: expected impact of anti-vascular endothelial growth factor (VEGF) therapy
British Journal of Ophthalmology 2011;95:1433-1436.